Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001051695 | SCV001215863 | pathogenic | Bethlem myopathy 1A | 2019-12-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg531Glyfs*6) in the COL6A1 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in COL6A1 are known to be pathogenic (PMID: 19884007, 20976770). This variant has not been reported in the literature in individuals with COL6A1-related conditions. This variant is not present in population databases (ExAC no frequency). |